BRENTWOOD, Tenn.--(BUSINESS WIRE)--PharmMD, a leading medication adherence healthcare technology company, has launched Adhere™, its medication-focused platform of integrated technology solutions that uses advanced analytics to stratify consumer populations, prioritize interventions and resolve gaps in care to achieve value-based care outcomes. Adhere directs performance-based alignment between PharmMD and its clients and enables risk sharing as part of a unique guarantee that each consumer measurement conversion fee will deliver ROI.
For more than a decade, PharmMD has helped Medicare Advantage, managed Medicaid and Commercial plans as well as self-insured employers improve in their pay-for-performance programs, such as Star Ratings. The technology platform and nationwide licensed clinical team guarantees pay-for-performance program success.
“The solutions incorporated in the Adhere platform have had over a decade of results improving Star Ratings and other value-based care initiatives,” said Jason Rose, chief executive officer at PharmMD. “In 2019, nearly half of the Star Ratings will be weighted on medication adherence-related measures, and plans that begin these interventions now are already off to a great start for the next performance year.”
Today the Adhere platform touches more than six million consumers with the support of Stratify™, PharmMD’s analytics engine that uses machine learning and big data processing to identify medication adherence and quality care gaps that, if addressed, help achieve better value-based care outcomes. Stratify powers two fully integrated solutions: Resolve™, a comprehensive clinical decision support solution featuring medication adherence-focused intervention services, and OptimizeMTM™, a Medication Therapy Management (MTM) solution that addresses client goals and regulatory requirements.
The Adhere platform, ideal for health plans, employers and at-risk providers, also includes data-driven tools. These include Quantify™, an analytics engine for stratifying and prioritizing budgetary investment scenarios across each plan contract quality measure; QiLink™, a clinical workflow tool that directs live consumer and provider engagement; P3Link™, a clinical decision support tool that efficiently guides Comprehensive Medication Reviews (CMR) for MTM programs as well as medication reconciliation and medication synchronization services; and Discern™, a business analytics solution that provides real-time client data visualization of outcomes and program performance.
About PharmMD
PharmMD is a technology solutions leader supporting health plans, self-insured employers and other risk-bearing entities for medication adherence insights and healthcare outcomes. PharmMD's Adhere platform now touches more than six million consumers through advanced analytics, technologies and engagement services that address the estimated $300 billion of unnecessary annual medical costs attributed to medication adherence issues. The company is headquartered in the Nashville suburb of Brentwood, Tennessee. For more information, please visit www.pharmmd.com.
